A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting.

Suzanna Hirsch Samuel NurkoEnju LiuRachel L Rosen

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)

The majority of patients responded to IPBI, with significant improvements seen in nausea, vomiting, and discomfort. Pyloric EndoFLIP tended to distinguish baseline delays in gastric emptying, but it did not predict IPBI response in this patient cohort.

Keyphrases

botulinum toxin
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
young adults
peritoneal dialysis
chemotherapy induced
prognostic factors
patient reported outcomes